Study Identifies CD38 Mutations That Confer Resistance to CD38-Targeting Antibodies in Patients with Multiple Myeloma | ASH Clinical News | American Society of Hematology

An analysis of #genomic data from patients with #MultipleMyeloma #MMsm showed that loss of #CD38 expression can occur after treatment with #antiCD38 antibodies, arising in 20% of patients analyzed, with three cases exhibiting a loss of both copies: ow.ly/IfmE50WXc76 #HemeSky #OncSky